comparing immediate removal and postoperative 1 day of urinary catheter after colorectal cancer surgery

Conditions: Colorectal Cancer; Postoperative Complication; Urinary Retention Postoperative; Enhanced Recovery After Surgery

Summary: the enhanced recovery after surgery (eras) program is widely applied in colorectal cancer surgery. among the early recovery programs after surgery, the timing of removal of the urinary catheter after surgery has been emphasized recently, but the specific timing is still under discussion. maintaining the urinary catheter after surgery is to prevent urinary retention after surgery, but it is known that the risk of urinary tract infection increases the longer it is maintained. previously, it was removed 3 days after colorectal cancer surgery, but several studies reported that even if it was removed earlier, the incidence of urinary retention did not increase, and rather the incidence of urinary tract infection decreased. in particular, by applying the early recovery program after surgery, factors related to patient recovery before, during, and after surgery are applied to help rapid recovery, and it has been reported that early removal of the urinary catheter has a positive effect on postoperative recovery and complications. therefore, it is necessary to prove that the timing of removal of the urinary catheter after surgery in colorectal cancer patients can help early recovery through clinical results such as patient recovery and occurrence of complications.

this study aims to demonstrate that removing the urinary drain immediately after colorectal cancer surgery is non-inferior to removing it on the first day (within 24 hours) after surgery in terms of the incidence of acute urinary retention. to evaluate the non-inferiority of the incidence of acute urinary retention (aur) according to the timing of urinary drain removal after surgery. secondary outcomes are the incidence of symptomatic urinary tract infection (uti), postvoid residual (pvr), length of hospital stay, postoperative pain score, and narcotic analgesic usage, early ambulation success rate, postoperative complication rate, and overactive bladder symptom assessment score for patient discomfort, etc., and to compare the clinical outcomes after surgery from various perspectives.

Eligibility criteria:
inclusion criteria: * 19 years old 80 years old * patients diagnosed with colorectal cancer who are eligible for radical resection surgery * patients who underwent open, laparoscopic, or robotic surgery * written informed consent exclusion criteria: * patients who have undergone two or more major abdominal surgeries, including lateral pelvic lymph node dissection, at the same time * patients who require continuous monitoring through a urinary catheter due to hemodynamic instability or massive bleeding, etc. * patients who have undergone conventional treatment in cases other than distant metastasis or r0 resection * patients who have developed complications related to the urinary system during surgery and require maintenance of a urinary catheter such as a urethral stent * patients who have undergone urinary surgery such as urethral stent placement, cystectomy, or urostomy in the past * patients who are on hemodialysis or peritoneal dialysis due to chronic renal failure * patients who cannot participate in a clinical trial at the discretion of a physician * patients who do not wish to participate in the study